Robert Schwimmer is a legal professional with extensive experience in corporate law. They served as General Counsel at Insys Therapeutics, Inc. from 2019 to 2020, and currently hold the position of VP, Diagnostics Business General Counsel at Envista Holdings Corporation since 2020. Previously, Robert worked as an Attorney at Snell & Wilmer from 2009 to 2017. Robert is pursuing a J.D. at Columbia University School of Law and holds an A.B. from Princeton University.
This person is not in any teams
This person is not in any offices